Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2026-01-04 @ 12:56 PM
Study NCT ID:
NCT04707703
Status:
TERMINATED
Last Update Posted:
2022-11-25
First Post:
2021-01-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis
Sponsor:
Jeffrey Jenks, MD, MPH
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
200639
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |